Decipher Labs Limited

BSE: 524752
Decipher Labs Limited - pharma in Shaikpet, Telangana, India. FY 2026 financials and compliance.
CIN L24230TG1986PLC006781 Incorporated 17 September 1986 ROC Hyderabad HQ Shaikpet, Telangana, India
Active Listed - BSE: 524752 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹14.05 Cr
▼ 37.85% YoY
Computed EBITDA · FY 2026
-₹3.17 Cr
▲ 46.38% YoY
Net profit · FY 2026
-₹3.08 Cr
▲ 39.29% YoY
Authorised capital
₹10.5 Cr
Registered with MCA
Paid-up capital
₹10.1 Cr
Issued & subscribed
Open charges
₹42.25 Lakh
Satisfied ₹1.4 Cr
Company age
40 yrs
Est. 1986
Last financials
Mar 2025
Balance sheet date

About Decipher Labs Limited

Data last updated: 14 July 2026

Decipher Labs Limited is a public limited company based in Shaikpet, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 17 September 1986, the company has been in operation for over 40 years.

Registered with ROC Hyderabad under CIN L24230TG1986PLC006781. Listed on BSE: 524752.

Capital: an authorised share capital of ₹10.5 Cr and a paid-up capital of ₹10.1 Cr. Formerly known as R. A. Labs (India) Limited and Ra Labs Limited. It is led by directors including Sushant Mohan Lal and Janakiram Ajjarapu.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: A – 2 Q2 5Th Floor Cyber Towers Hitech City, Shaikpet, Telangana, India – 500081.

As per BSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹14.05 Cr, a decline of 37.85% compared to the previous year. The net worth stands at ₹8.24 Cr (down 63.95% YoY). Total assets are valued at ₹9 Cr (down 65.09% YoY).

Its group structure includes 1 subsidiary.

The company is associated with 2 brands - Combat Drugs, Decipher Labs. As per MCA filings, the company has open charges of ₹42.25 Lakh and satisfied charges of ₹1.4 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website decipherlabs.in.

Company Details of Decipher Labs Limited
CIN L24230TG1986PLC006781
Registration Number 006781
Incorporation Date 17 September 1986
ROC Hyderabad
Listing Status Listed (BSE: 524752)
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Dalavath Amar Singh Whole-Time Director Sushant Mohan Lal Director Janakiram Ajjarapu Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    decipherlabs.in
  • Social Media
    Locked
  • Registered Address
    A – 2 Q2 5Th Floor Cyber Towers Hitech City, Shaikpet, Telangana, India – 500081
  • Industry
    Pharma, Drug Formulation & Development
Company report
Decipher Labs Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Decipher Labs Limited report

Financials, compliance, directors, charges, ownership and filings for Decipher Labs Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Decipher Labs Limited

Decipher Labs Limited has undergone 11 name changes throughout its history. The current legal name is Decipher Labs Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Decipher Labs Limited Current
R. A. Labs (India) Limited Previous
Ra Labs Limited Previous
R.A Labs (India) Limited Previous
R.A. Labs Limited Previous
Combat Drugs Limited Previous
Ra Labs (India) Limited Previous
Combat Drugs And Softech Limited Previous
R.A Labs Limited Previous
3I Labs Limited Previous
3Rd I. Labs Limited Previous
R.A. Labs (India) Limited Previous

CIN History of Decipher Labs Limited

Decipher Labs Limited has one previous CIN (Corporate Identification Number): L24230AP1986PLC006781. The current CIN is L24230TG1986PLC006781, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24230TG1986PLC006781 Current
L24230AP1986PLC006781 Previous

Associated Brands with Decipher Labs Limited

Decipher Labs Limited operates two associated brands: Combat Drugs and Decipher Labs. These brands represent Decipher Labs Limited's diversified market presence and brand portfolio.

Brand Description Website
Combat Drugs
Formulations are manufactured and custom services are provided in pharmaceuticals. combatdrugs.in
Decipher Labs
Healthcare company that develops and commercializes genomic tests for personalized cancer treatment, focusing on prostate and bladder cancer diagnosis and treatment planning decipherlabs.in

Competitors & Alternatives of Decipher Labs Limited

Brands and companies operating in the same space as Decipher Labs Limited include WuXi AppTec, ANI Pharmaceuticals, Aptar and 6 more.

Competitor Description Location Founded
WuXi AppTec WuXi AppTec Provider of CRO and CDMO services Shanghai, China, China 2000
ANI Pharmaceuticals ANI Pharmaceuticals Branded and generic prescription drugs are developed, manufactured, and marketed. Baudette, United States, United States 1996
Aptar Aptar Regulatory support, brand differentiation, and prototyping services are provided. Crystal Lake, United States, United States 1992
CHEPLAPHARM CHEPLAPHARM Branded pharmaceutical products are developed, marketed, and distributed globally. Mesekenhagen, Germany, Germany 1998
Red Nucleus Red Nucleus Advisory, scientific, and medical communications provided for pharmaceutical industry. Yardley, United States, United States 2014
Ipsen Ipsen Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes - 1929
Eurofins Scientific Eurofins Scientific Laboratory testing and contract research services are provided globally. Luxembourg, Luxembourg, Luxembourg 1987
China Medical System China Medical System Generic formulations including tablets, capsules, liquids, and injectables are manufactured. Shenzhen, China, China 1992
Aliada Therapeutics Aliada Therapeutics Provider of drug research & development services for multiple therapeutic areas Boston, United States, United States 2021

Business Activity of Decipher Labs Limited

Decipher Labs Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Decipher Labs Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Decipher Labs Limited

Decipher Labs Limited is audited by M/s. Ramanatham & Co. (ICAI peer reviewed, certificate valid till 2026-05-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
M/s. Ramanatham & Co. (ICAI peer reviewed, certificate valid till 2026-05-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Decipher Labs Limited

Decipher Labs Limited is currently managed by 6 directors, with 14 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Sushant Mohan Lal
Also directs: Gincom Ventures Llp
Director 19 May 2006 20 Years 2 Months Current
Janakiram Ajjarapu
Also directs: Icp Solutions Limited
Director 14 Feb 2023 3 Years 5 Months Current
Venkateswara Rao Gudipudi Director 13 Aug 2022 3 Years 11 Months Current
Lakshmi Vijaya Nimmala Director 14 Feb 2023 3 Years 5 Months Current
Dalavath Amar Singh Whole-Time Director 13 Nov 2025 0 Years 8 Months Current
Gayathri Raghuram Director 04 Sep 2023 2 Years 10 Months Current
View all directors

Financials of Decipher Labs Limited FY 2026 filings available

Decipher Labs Limited reported revenue of ₹14.05 Cr (down 37.85% YoY) for FY 2026.

Revenue · FY 2026
₹14.05 Cr ▼ 37.85%
Profit · FY 2026
-₹3.08 Cr ▲ 39.29%
Computed EBITDA · FY 2026
-₹3.17 Cr ▲ 46.38%
Revenue₹ Cr · Consolidated0255075FY 2019: ₹8 Cr8.1FY 2019FY 2020: ₹24 Cr · +197.7% YoY24+197.7%FY 2020FY 2021: ₹56 Cr · +131.6% YoY55.6+131.6%FY 2021FY 2022: ₹65 Cr · +17.6% YoY65.3+17.6%FY 2022FY 2023: ₹46 Cr · -30.2% YoY45.6-30.2%FY 2023FY 2024: ₹36 Cr · -21.3% YoY35.9-21.3%FY 2024FY 2025: ₹23 Cr · -37% YoY22.6-37%FY 2025FY 2026: ₹14 Cr · -37.8% YoY14.1-37.8%FY 2026
Net Profit₹ Cr · Consolidated-10-5051015FY 2019: ₹0 Cr0.4FY 2019FY 2020: ₹1 Cr · +171.6% YoY1.1+171.6%FY 2020FY 2021: ₹1 Cr · +27.4% YoY1.4+27.4%FY 2021FY 2022: ₹12 Cr · +751.6% YoY11.9+751.6%FY 2022FY 2023: ₹1 Cr (loss) · -108% YoY-1FY 2023FY 2024: ₹2 Cr (loss) · -75.2% YoY-1.7FY 2024FY 2025: ₹5 Cr (loss) · -203.2% YoY-5.1FY 2025FY 2026: ₹3 Cr (loss) · +39.3% YoY-3.1FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year02.557.5Q1'25: ₹7 Cr7.4Q1'25Q2'25: ₹6 Cr5.9Q2'25Q3'25: ₹6 Cr5.8Q3'25Q4'25: ₹4 Cr3.5Q4'25Q1'26: ₹3 Cr · -60.7% YoY2.9-60.7%Q1'26Q2'26: ₹4 Cr · -26.5% YoY4.3-26.5%Q2'26Q3'26: ₹3 Cr · -44.7% YoY3.2-44.7%Q3'26Q4'26: ₹4 Cr · +3% YoY3.6+3%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹14.05 Cr ₹22.61 Cr ₹35.88 Cr ₹45.57 Cr ₹65.32 Cr ₹55.56 Cr ₹23.99 Cr ₹8.06 Cr
Other Income ₹22.09 Lakh ₹1.32 Cr ₹41.65 Lakh ₹7.37 Cr ₹7.67 Cr ₹64.56 Lakh ₹27.29 Lakh ₹0
Total Income ₹14.27 Cr ₹23.93 Cr ₹36.3 Cr ₹52.94 Cr ₹73 Cr ₹56.21 Cr ₹24.26 Cr ₹8.06 Cr
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹6.15 Cr
Purchases of Stock-in-Trade ₹64.5 Lakh ₹67.25 Lakh ₹3.14 Cr ₹47.25 Lakh ₹15.53 Lakh ₹15.04 Lakh ₹61.85 Lakh ₹0
Changes in Inventories -₹40,000 ₹0 ₹0 ₹4.42 Lakh ₹0 ₹27.45 Lakh ₹28,000 -₹22.42 Lakh
Employee Benefit Expense ₹14.99 Cr ₹21.39 Cr ₹27.75 Cr ₹41.19 Cr ₹47.49 Cr ₹47.48 Cr ₹19.57 Cr ₹1.1 Cr
Finance Costs ₹0 ₹0 ₹21.76 Lakh ₹42.69 Lakh ₹47.66 Lakh ₹1.13 Cr ₹72.15 Lakh ₹0
Depreciation & Amortisation ₹51.63 Lakh ₹47.63 Lakh ₹45.27 Lakh ₹42.75 Lakh ₹86.66 Lakh ₹81.93 Lakh ₹55.61 Lakh ₹6,000
Other Expenses ₹1.82 Cr ₹7.78 Cr ₹5.95 Cr ₹12.3 Cr ₹11.66 Cr ₹4.2 Cr ₹1.32 Cr ₹59.61 Lakh
Total Expenses ₹17.96 Cr ₹30.32 Cr ₹37.51 Cr ₹54.86 Cr ₹60.64 Cr ₹54.06 Cr ₹22.79 Cr ₹7.62 Cr
Profit Before Exceptional Items & Tax -₹3.68 Cr -₹6.39 Cr -₹1.21 Cr -₹1.92 Cr ₹12.36 Cr ₹2.14 Cr ₹1.47 Cr ₹44.08 Lakh
Exceptional Items ₹0 ₹0 ₹0 -₹2.24 Cr ₹0 ₹0 ₹0 ₹0
Profit Before Tax -₹3.68 Cr -₹6.39 Cr -₹1.21 Cr -₹4.16 Cr ₹12.36 Cr ₹2.14 Cr ₹1.47 Cr ₹44.08 Lakh
Total Tax Expense -₹60.06 Lakh -₹1.31 Cr ₹46.45 Lakh -₹1.48 Cr ₹97.22 Lakh ₹74.03 Lakh ₹36.52 Lakh ₹3.54 Lakh
Net Profit -₹3.08 Cr -₹5.08 Cr -₹1.68 Cr -₹95.66 Lakh ₹11.94 Cr ₹1.4 Cr ₹1.1 Cr ₹40.54 Lakh
  attributable to Owners - -₹5.08 Cr - ₹0 - ₹0 ₹0 ₹0
  attributable to NCI - ₹0 - ₹0 - ₹0 ₹0 ₹0
Other Comprehensive Income ₹89.37 Lakh ₹16.67 Lakh ₹32.77 Lakh ₹0 ₹0 -₹27.57 Lakh ₹49.66 Lakh ₹10,000
Total Comprehensive Income -₹2.19 Cr -₹4.91 Cr -₹1.35 Cr -₹95.66 Lakh ₹11.94 Cr ₹1.13 Cr ₹1.6 Cr ₹40.64 Lakh
EBITDA (computed) -₹3.17 Cr -₹5.91 Cr -₹54.08 Lakh -₹1.06 Cr ₹13.7 Cr ₹4.1 Cr ₹2.74 Cr ₹44.14 Lakh
Basic EPS ₹-3.05 ₹-5.03 ₹-1.66 ₹-2.66 ₹11.27 ₹1.39 ₹0.11 ₹0.51
Diluted EPS ₹-3.05 ₹-5.03 ₹-1.66 ₹-2.66 ₹11.27 ₹1.39 ₹0.11 ₹0.51
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹9 Cr ₹25.76 Cr ₹33.63 Cr ₹28.16 Cr ₹41.95 Cr ₹38.72 Cr ₹11.65 Cr ₹6.34 Cr
Non-current Assets ₹8.83 Cr ₹4.71 Cr ₹8.96 Cr ₹8.08 Cr ₹3.72 Cr ₹16.18 Cr ₹8.52 Cr ₹2.52 Lakh
Current Assets ₹16.78 Lakh ₹21.05 Cr ₹24.68 Cr ₹20.08 Cr ₹38.23 Cr ₹22.54 Cr ₹3.13 Cr ₹6.32 Cr
Property, Plant & Equipment ₹12 Lakh ₹82.83 Lakh ₹88 Lakh ₹96.63 Lakh ₹33.47 Lakh ₹48.65 Lakh ₹10.83 Lakh ₹70,000
Inventories ₹40,000 ₹0 ₹0 ₹0 ₹4.42 Lakh ₹4.42 Lakh ₹31.87 Lakh ₹32.15 Lakh
Trade Receivables ₹3.39 Lakh ₹4.22 Cr ₹7.8 Cr ₹9.85 Cr ₹12.79 Cr ₹11.67 Cr ₹17.45 Lakh ₹3.46 Cr
Cash & Equivalents ₹2.5 Lakh ₹2.81 Cr ₹9.31 Cr ₹7.42 Cr ₹15.41 Cr ₹6.98 Cr ₹0 ₹57,000
Equity (Net Worth) ₹8.24 Cr ₹22.86 Cr ₹21.86 Cr ₹23.21 Cr ₹24.17 Cr ₹13.69 Cr ₹11.07 Cr ₹2.53 Cr
Equity Share Capital ₹10.1 Cr ₹10.1 Cr ₹10.1 Cr ₹10.1 Cr ₹10.1 Cr ₹10.1 Cr ₹10.1 Cr ₹8 Cr
Borrowings (Non-current) ₹0 ₹0 ₹0 ₹94.94 Lakh ₹6.67 Cr ₹6.71 Cr ₹0 ₹0
Borrowings (Current) ₹50.32 Lakh ₹24.45 Lakh ₹0 ₹0 ₹3.65 Cr ₹2.04 Cr ₹23.04 Lakh ₹20.08 Lakh
Total Debt (computed) ₹50.32 Lakh ₹24.45 Lakh ₹0 ₹94.94 Lakh ₹10.32 Cr ₹8.76 Cr ₹23.04 Lakh ₹20.08 Lakh
Current Liabilities ₹75.46 Lakh ₹2.91 Cr ₹11.77 Cr ₹4.01 Cr ₹11.11 Cr ₹17.31 Cr ₹58.34 Lakh ₹3.82 Cr
Total Liabilities ₹75.46 Lakh ₹2.91 Cr ₹11.77 Cr ₹4.96 Cr ₹17.78 Cr ₹25.03 Cr ₹58.34 Lakh ₹3.82 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow -₹2.08 Cr -₹9.82 Cr ₹4.85 Cr -₹1.56 Cr ₹8.26 Cr
Investing Cash Flow -₹24.09 Lakh ₹3.07 Cr -₹1.79 Cr -₹4.28 Cr -₹45.33 Lakh
Financing Cash Flow ₹25.86 Lakh ₹24.45 Lakh -₹1.17 Cr -₹2.15 Cr ₹62.13 Lakh
Capital Expenditure ₹24.09 Lakh ₹5.69 Lakh ₹5.84 Lakh ₹78.3 Lakh ₹19.92 Lakh
Free Cash Flow (computed) -₹2.32 Cr -₹9.88 Cr ₹4.8 Cr -₹2.35 Cr ₹8.07 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹2.07 Cr -₹6.51 Cr ₹1.9 Cr -₹7.99 Cr ₹8.43 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹3.6 Cr ₹3.21 Cr ₹4.31 Cr ₹2.92 Cr ₹3.5 Cr ₹5.8 Cr ₹5.87 Cr ₹7.44 Cr
Other Income ₹17.37 Lakh ₹1.55 Lakh ₹2.05 Lakh ₹1.12 Lakh ₹87.05 Lakh ₹16.87 Lakh ₹12.09 Lakh ₹15.81 Lakh
Total Income ₹3.78 Cr ₹3.23 Cr ₹4.33 Cr ₹2.93 Cr ₹4.37 Cr ₹5.97 Cr ₹5.99 Cr ₹7.6 Cr
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹40,000 ₹0 ₹0 ₹64.1 Lakh ₹23 Lakh ₹15 Lakh ₹0 ₹29.25 Lakh
Changes in Inventories -₹40,000 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹2.68 Cr ₹3.54 Cr ₹4.05 Cr ₹4.73 Cr ₹3.76 Cr ₹5.83 Cr ₹6.69 Cr ₹5.11 Cr
Finance Costs ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Depreciation & Amortisation ₹14.86 Lakh ₹12.52 Lakh ₹12.54 Lakh ₹11.71 Lakh ₹12.65 Lakh ₹12.2 Lakh ₹11.5 Lakh ₹11.28 Lakh
Other Expenses ₹69.93 Lakh ₹10.09 Lakh ₹14.26 Lakh ₹87.3 Lakh ₹6.08 Cr ₹45.79 Lakh ₹51.28 Lakh ₹72.24 Lakh
Total Expenses ₹3.53 Cr ₹3.76 Cr ₹4.32 Cr ₹6.36 Cr ₹10.2 Cr ₹6.56 Cr ₹7.32 Cr ₹6.24 Cr
Profit Before Exceptional Items & Tax ₹25.16 Lakh -₹53.31 Lakh ₹1.89 Lakh -₹3.42 Cr -₹5.83 Cr -₹58.47 Lakh -₹1.33 Cr ₹1.36 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹25.16 Lakh -₹53.31 Lakh ₹1.89 Lakh -₹3.42 Cr -₹5.83 Cr -₹58.47 Lakh -₹1.33 Cr ₹1.36 Cr
Total Tax Expense ₹60.95 Lakh ₹57,000 -₹12,000 ₹44,000 -₹1.73 Cr ₹80,000 ₹6,000 ₹41.13 Lakh
Net Profit -₹35.79 Lakh -₹53.88 Lakh ₹2.01 Lakh -₹3.43 Cr -₹4.11 Cr -₹59.27 Lakh -₹1.33 Cr ₹94.66 Lakh
  attributable to Owners - -₹53.88 Lakh ₹2.01 Lakh -₹3.43 Cr -₹4.11 Cr -₹59.27 Lakh -₹38.14 Lakh -
  attributable to NCI - ₹0 - - ₹0 ₹0 - -
Other Comprehensive Income ₹88.55 Lakh ₹31.45 Lakh -₹59.08 Lakh ₹28.45 Lakh -₹33.47 Lakh ₹22.12 Lakh ₹28.26 Lakh -₹24,000
Total Comprehensive Income ₹52.76 Lakh -₹22.43 Lakh -₹57.07 Lakh -₹3.14 Cr -₹4.44 Cr -₹37.15 Lakh -₹1.05 Cr ₹94.42 Lakh
EBITDA (computed) ₹40.02 Lakh -₹40.79 Lakh ₹14.43 Lakh -₹3.31 Cr -₹5.71 Cr -₹46.27 Lakh -₹1.21 Cr ₹1.47 Cr
Basic EPS ₹-0.35 ₹-0.53 ₹0.02 ₹-3.39 ₹-4.07 ₹-0.59 ₹-1.31 ₹0.94
Diluted EPS ₹-0.35 ₹-0.53 ₹0.02 ₹-3.39 ₹-4.07 ₹-0.59 ₹-1.31 ₹0.94
Latest 8 quarters shown.
Segment · Q4 FY26 (latest quarter) Revenue Result (PBIT) Assets Liabilities
Manufacturing and Trading of Pharmaceutical drugs ₹0 ₹7.73 Lakh ₹9.14 Cr ₹75.47 Lakh
Consultancy Services ₹3.6 Cr ₹17.44 Lakh ₹15.2 Cr ₹2.91 Cr
Segment · FY 2026 (annual) Revenue Result (PBIT) Assets Liabilities
Manufacturing and Trading of Pharmaceutical drugs ₹67.5 Lakh -₹17.7 Lakh - -
Consultancy Services ₹13.38 Cr -₹3.51 Cr - -
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹1.14 Cr ₹85.32 Lakh ₹3.53 Cr ₹81 Lakh ₹98.84 Lakh ₹97.6 Lakh ₹1.42 Cr ₹6.78 Cr
Other Income ₹13,000 ₹2.28 Lakh ₹1.99 Lakh ₹2.82 Lakh ₹4.59 Lakh ₹14.43 Lakh ₹1.32 Lakh ₹88,000
Total Income ₹1.14 Cr ₹87.6 Lakh ₹3.55 Cr ₹83.82 Lakh ₹1.03 Cr ₹1.12 Cr ₹1.44 Cr ₹6.79 Cr
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹6.15 Cr
Purchases of Stock-in-Trade ₹64.5 Lakh ₹67.25 Lakh ₹3.14 Cr ₹47.25 Lakh ₹15.53 Lakh ₹15.04 Lakh ₹61.85 Lakh ₹0
Changes in Inventories -₹40,000 ₹0 ₹0 ₹4.42 Lakh ₹0 ₹27.44 Lakh ₹28,000 -₹22.42 Lakh
Employee Benefit Expense ₹17.53 Lakh ₹23.43 Lakh ₹16.99 Lakh ₹20.11 Lakh ₹23.32 Lakh ₹19.85 Lakh ₹32.01 Lakh ₹16.68 Lakh
Finance Costs ₹0 ₹0 ₹0 ₹0 ₹0 ₹1.79 Lakh ₹0 ₹0
Depreciation & Amortisation ₹1.8 Lakh ₹1.67 Lakh ₹1.45 Lakh ₹5.74 Lakh ₹5.01 Lakh ₹4.15 Lakh ₹35,000 ₹6,000
Other Expenses ₹54.07 Lakh ₹39.14 Lakh ₹20.42 Lakh ₹46.03 Lakh ₹23.78 Lakh ₹33.72 Lakh ₹32.43 Lakh ₹32.25 Lakh
Total Expenses ₹1.38 Cr ₹1.31 Cr ₹3.53 Cr ₹1.24 Cr ₹67.64 Lakh ₹1.02 Cr ₹1.27 Cr ₹6.41 Cr
Profit Before Exceptional Items & Tax -₹23.83 Lakh -₹43.89 Lakh ₹2.52 Lakh -₹39.73 Lakh ₹35.79 Lakh ₹10.04 Lakh ₹16.75 Lakh ₹37.69 Lakh
Exceptional Items ₹0 ₹0 ₹0 -₹2.24 Cr ₹0 ₹0 ₹0 ₹0
Profit Before Tax -₹23.83 Lakh -₹43.89 Lakh ₹2.52 Lakh -₹2.64 Cr ₹35.79 Lakh ₹10.04 Lakh ₹16.75 Lakh ₹37.69 Lakh
Total Tax Expense ₹85,000 ₹13,000 ₹18,000 -₹2.14 Lakh -₹25,000 ₹42,000 -₹5,000 ₹1,000
Net Profit -₹24.68 Lakh -₹44.02 Lakh ₹2.34 Lakh -₹2.62 Cr ₹36.04 Lakh ₹9.62 Lakh ₹16.8 Lakh ₹37.68 Lakh
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income -₹24.68 Lakh -₹44.02 Lakh ₹2.34 Lakh -₹2.62 Cr ₹36.04 Lakh ₹9.62 Lakh ₹16.8 Lakh ₹37.68 Lakh
EBITDA (computed) -₹22.03 Lakh -₹42.22 Lakh ₹3.97 Lakh -₹33.99 Lakh ₹40.8 Lakh ₹15.98 Lakh ₹17.1 Lakh ₹37.75 Lakh
Basic EPS ₹-0.24 ₹-0.44 ₹0.02 ₹-2.59 ₹0.36 ₹0.10 ₹0.17 ₹0.47
Diluted EPS ₹-0.24 ₹-0.44 ₹0.02 ₹-2.59 ₹0.36 ₹0.10 ₹0.17 ₹0.47
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹9 Cr ₹9.18 Cr ₹12.76 Cr ₹8.99 Cr ₹11.6 Cr ₹11.4 Cr ₹11.65 Cr ₹5.84 Cr
Non-current Assets ₹8.83 Cr ₹8.85 Cr ₹8.79 Cr ₹8.81 Cr ₹9 Cr ₹8.67 Cr ₹8.52 Cr ₹5.56 Lakh
Current Assets ₹16.78 Lakh ₹32.44 Lakh ₹3.97 Cr ₹18.4 Lakh ₹2.6 Cr ₹2.73 Cr ₹3.13 Cr ₹5.78 Cr
Property, Plant & Equipment ₹12 Lakh ₹13.8 Lakh ₹10.43 Lakh ₹11.87 Lakh ₹33.46 Lakh ₹25.55 Lakh ₹10.83 Lakh ₹70,000
Inventories ₹40,000 ₹0 ₹0 ₹0 ₹4.42 Lakh ₹4.42 Lakh ₹31.87 Lakh ₹32.15 Lakh
Trade Receivables ₹3.39 Lakh ₹22.68 Lakh ₹3.95 Cr ₹12.74 Lakh ₹21.54 Lakh ₹41.42 Lakh ₹17.45 Lakh ₹3.04 Cr
Cash & Equivalents ₹2.5 Lakh ₹5.47 Lakh ₹2.65 Lakh ₹5.63 Lakh ₹4.76 Lakh ₹1.93 Lakh ₹0 ₹55,000
Equity (Net Worth) ₹8.24 Cr ₹8.49 Cr ₹8.93 Cr ₹8.9 Cr ₹11.52 Cr ₹11.16 Cr ₹11.07 Cr ₹2.5 Cr
Equity Share Capital ₹10.1 Cr ₹10.1 Cr ₹10.1 Cr ₹10.1 Cr ₹10.1 Cr ₹10.1 Cr ₹10.1 Cr ₹8 Cr
Borrowings (Non-current) ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Borrowings (Current) ₹50.32 Lakh ₹24.45 Lakh ₹0 ₹0 ₹0 ₹13.63 Lakh ₹23.04 Lakh ₹13.87 Lakh
Total Debt (computed) ₹50.32 Lakh ₹24.45 Lakh ₹0 ₹0 ₹0 ₹13.63 Lakh ₹23.04 Lakh ₹13.87 Lakh
Current Liabilities ₹75.46 Lakh ₹69.09 Lakh ₹3.83 Cr ₹8.55 Lakh ₹8.04 Lakh ₹23.19 Lakh ₹58.34 Lakh ₹3.34 Cr
Total Liabilities ₹75.46 Lakh ₹69.09 Lakh ₹3.83 Cr ₹8.55 Lakh ₹8.18 Lakh ₹23.57 Lakh ₹58.34 Lakh ₹3.34 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow -₹28.84 Lakh ₹7.49 Lakh -₹2.95 Lakh -₹7.64 Lakh ₹54.78 Lakh
Investing Cash Flow ₹0 -₹4.67 Lakh ₹0 ₹8.5 Lakh -₹38.32 Lakh
Financing Cash Flow ₹25.87 Lakh ₹0 ₹0 ₹0 -₹13.63 Lakh
Capital Expenditure ₹0 ₹5.69 Lakh ₹0 -₹8.5 Lakh ₹12.91 Lakh
Free Cash Flow (computed) -₹28.84 Lakh ₹1.8 Lakh -₹2.95 Lakh -₹16.14 Lakh ₹41.87 Lakh
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹2.97 Lakh ₹2.82 Lakh -₹2.95 Lakh ₹86,000 ₹2.83 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹6.69 Lakh ₹13.4 Lakh ₹8.8 Lakh ₹84.65 Lakh ₹22.6 Lakh ₹16 Lakh ₹8.38 Lakh ₹38.34 Lakh
Other Income ₹11,000 ₹0 ₹2,000 ₹0 ₹1,000 ₹33,000 ₹1.77 Lakh ₹17,000
Total Income ₹6.8 Lakh ₹13.4 Lakh ₹8.82 Lakh ₹84.65 Lakh ₹22.61 Lakh ₹16.33 Lakh ₹10.15 Lakh ₹38.51 Lakh
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹40,000 ₹0 ₹0 ₹64.1 Lakh ₹23 Lakh ₹15 Lakh ₹0 ₹29.25 Lakh
Changes in Inventories -₹40,000 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹5.32 Lakh ₹4.51 Lakh ₹3.85 Lakh ₹3.85 Lakh ₹8.3 Lakh ₹3.01 Lakh ₹4.4 Lakh ₹7.72 Lakh
Finance Costs ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Depreciation & Amortisation ₹45,000 ₹45,000 ₹45,000 ₹45,000 ₹45,000 ₹45,000 ₹45,000 ₹32,000
Other Expenses ₹18.38 Lakh ₹9.28 Lakh ₹16.19 Lakh ₹10.22 Lakh ₹7.3 Lakh ₹6.96 Lakh ₹11.05 Lakh ₹13.83 Lakh
Total Expenses ₹24.15 Lakh ₹14.24 Lakh ₹20.49 Lakh ₹78.62 Lakh ₹39.05 Lakh ₹25.42 Lakh ₹15.9 Lakh ₹51.12 Lakh
Profit Before Exceptional Items & Tax -₹17.35 Lakh -₹84,000 -₹11.67 Lakh ₹6.03 Lakh -₹16.44 Lakh -₹9.09 Lakh -₹5.75 Lakh -₹12.61 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax -₹17.35 Lakh -₹84,000 -₹11.67 Lakh ₹6.03 Lakh -₹16.44 Lakh -₹9.09 Lakh -₹5.75 Lakh -₹12.61 Lakh
Total Tax Expense -₹4,000 ₹57,000 -₹12,000 ₹44,000 ₹37,000 -₹12,000 -₹11,000 ₹47,000
Net Profit -₹17.31 Lakh -₹1.41 Lakh -₹11.55 Lakh ₹5.59 Lakh -₹16.81 Lakh -₹8.97 Lakh -₹5.64 Lakh -₹13.08 Lakh
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income -₹17.31 Lakh -₹1.41 Lakh -₹11.55 Lakh ₹5.59 Lakh -₹16.81 Lakh -₹8.97 Lakh -₹5.64 Lakh -₹13.08 Lakh
EBITDA (computed) -₹16.9 Lakh -₹39,000 -₹11.22 Lakh ₹6.48 Lakh -₹15.99 Lakh -₹8.64 Lakh -₹5.3 Lakh -₹12.29 Lakh
Basic EPS ₹-0.17 ₹-0.01 ₹-0.11 ₹0.06 ₹-0.17 ₹-0.09 ₹-0.06 ₹-0.13
Diluted EPS ₹-0.17 ₹-0.01 ₹-0.11 ₹0.06 ₹-0.17 ₹-0.09 ₹-0.06 ₹-0.13
Latest 8 quarters shown.
Segment · Q4 FY26 (latest quarter) Revenue Result (PBIT) Assets Liabilities
Manufacturing and Trading of Pharmaceutical drugs ₹0 -₹10.07 Lakh ₹9 Cr ₹75.47 Lakh
Consultancy Services ₹6.69 Lakh -₹7.28 Lakh ₹0 ₹0
Segment · FY 2026 (annual) Revenue Result (PBIT) Assets Liabilities
Manufacturing and Trading of Pharmaceutical drugs ₹67.5 Lakh -₹14.17 Lakh - -
Consultancy Services ₹46.04 Lakh -₹9.66 Lakh - -
Want more history and ratios?
You're viewing the latest exchange-filed financials for Decipher Labs Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Decipher Labs Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 16.43%, foreign institutional investors hold 0.00%, retail and other public shareholders hold 83.57% of Decipher Labs Limited. The company had 29,596 shareholders on record.

Promoters: 16.43%Retail & Others: 83.57%
Mar 2026
QUARTER
16.43% Promoters
83.57% Retail & Others
Promoter holding - history
Now 16.43% · Mar 2026High 16.43% · Jun 2023Low 16.43% · Jun 2023
15%15.8%16.5%17.3%18%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 16.43%Sep 2023: 16.43%Dec 2023: 16.43%Mar 2024: 16.43%Jun 2024: 16.43%Sep 2024: 16.43%Dec 2024: 16.43%Mar 2025: 16.43%Jun 2025: 16.43%Sep 2025: 16.43%Dec 2025: 16.43%Mar 2026: 16.43%16.43%16.43%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters16.43%16.43%16.43%16.43%16.43%16.43%
Public83.57%83.57%83.57%83.57%83.57%83.57%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters16.43%16.43%16.43%
Public83.57%83.57%83.57%
Promoter change (YoY, %pts)+0.00+0.00-

Group Structure of Decipher Labs Limited

Decipher Labs Limited has 1 subsidiary company. This group structure data is as of FY 2021. The corporate group structure reflects Decipher Labs Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Icp Solutions Private Limited U72500TG2018PTC124743 -

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Decipher Labs Limited

Open charges
₹42.25 Lakh
Satisfied charges
₹1.4 Cr
Breakdown by lending institutions
The Dhanlakshmi Bank Ltd₹0.40 Cr
Corporation Bank₹0.02 Cr
Latest charge details
DateLenderAmountStatus
20 Nov 1996 The Dhanlakshmi Bank Ltd ₹40 Lakh Open
07 Feb 1989 Corporation Bank ₹2.25 Lakh Open
16 Jul 1997 Vijaya Bank ₹40 Lakh Satisfied
21 Nov 1996 The Dhanlakshmi Bank Ltd ₹40 Lakh Satisfied
07 May 1996 The Dhanlakshmi Bank Ltd ₹60 Lakh Satisfied

Total charge records: 5 View all charges

Employees and EPFO Compliance at Decipher Labs Limited

View historical data on people associated with Decipher Labs Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Decipher Labs Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Decipher Labs Limited

Premium access

GST registrations and filing compliance for Decipher Labs Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Decipher Labs Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Decipher Labs Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Decipher Labs Limited

Premium access

MSME payment history for Decipher Labs Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Decipher Labs Limited

Premium access

Corporate group structure for Decipher Labs Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Decipher Labs Limited

Premium access

MCA filings and documents for Decipher Labs Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Decipher Labs Limited

Directors
13 Nov 2025
Dalavath Amar Singh was appointed as a Whole-time director on 13 Nov 2025 & has been associated with this company since 8 months 7 days.
Activity
30 Sep 2025
Decipher Labs Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Decipher Labs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Directors
29 Jan 2025
Preeti Singh was appointed as a Company Secretary on 29 Jan 2025 & has been associated with this company since 1 year 5 months.
Directors
04 Sep 2023
Gayathri Raghuram was appointed as a Director on 04 Sep 2023 & has been associated with this company since 2 years 10 months.
Directors
14 Feb 2023
Janakiram Ajjarapu was appointed as a Director on 14 Feb 2023 & has been associated with this company since 3 years 5 months.

Recent News on Decipher Labs Limited

Frequently Asked Questions about Decipher Labs Limited

Decipher Labs Limited is an active public limited company in the pharma sector based in Shaikpet, Telangana, India. It was incorporated on 17 September 1986 (40+ years old) and is registered under CIN L24230TG1986PLC006781. Listed on BSE: 524752.

Decipher Labs Limited reported revenue of ₹14.05 Cr for FY 2026 (down 37.85% YoY) based on consolidated BSE filings.

The current directors of Decipher Labs Limited are:

The primary industry of Decipher Labs Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Decipher Labs Limited is listed on BSE with code 524752.

Decipher Labs Limited can be reached at the registered office: A – 2 Q2 5Th Floor Cyber Towers Hitech City, Shaikpet, Telangana, India – 500081, or through the website decipherlabs.in.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available